Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spobiotic Research Center is a specialized biotechnology research organization dedicated to the development of spore-based therapeutics and vaccines. The center utilizes a proprietary platform based on Bacillus subtilis spores, which serve as robust, heat-stable delivery vehicles for antigens and therapeutic proteins. Their primary research focus includes the development of needle-free mucosal vaccines for respiratory infections and live biotherapeutic products for gastrointestinal disorders. By leveraging the natural stability of bacterial spores, the center aims to create medical solutions that do not require cold-chain logistics, making them ideal for global health applications. The center operates in close collaboration with SporeGen Ltd and ANABIO R&D to translate basic spore science into clinical candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spobiotic Research Center.